About | Free Trial

Last Update

2016-04-26T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Matthew Brow?

Mr. Matthew Brow E.

Vice President

McKesson Specialty Health

Direct Phone: (202) ***-****       

McKesson Specialty Health

10101 Woodloch Forest Dr.

The Woodlands, Texas 77380

United States

Company Description

McKesson Specialty Health, a division of McKesson Corporation, empowers the community patient care delivery system by helping community practices advance the science, technology and quality of care. Through innovative clinical, research, business and oper... more

Find other employees at this company (534)

Background Information

Employment History

Vice President, Govt. Relations and Public Policy

US Oncology Inc

Affiliations

Fellow
University of Virginia's Sorensen Institute of Political Leadership

Board Member
Christmas

Member of Government Affairs Committee
Virginia Peninsula Chamber of Commerce

Member of Pi Alpha Theta History Honorary Society and A Member
Phi Gamma Delta Fraternity

Education

BA
History and Political Science
University of Richmond , Virginia

Bachelor of Arts Degree
History and Political Science
University of Richmond

Matthew Farber , MA

Web References (109 Total References)


MetroMed

metromedkc.org [cached]

How Policy Will Affect the Future of Cancer Care Metro Med is excited to host "How Policy Will Affect the Future of Cancer Care" with Matt Brow, VP of Public Policy for McKesson Specialty Health, this Tuesday, August 19th from 5:00 - 7:00 pm at the Metro Med offices on... Continue reading >


MetroMed

metromedkc.org [cached]

"The most likely thing is oncologists are going to start acting more like coaches of the team rather than the players and the quarterbacks," said health care lobbyist Matt Brow. "There will be a lot more nurse practitioners in the mix, a lot more physician assistants doing things, particularly around follow-up."

Brow works in Washington, D.C., as vice president of public policy for McKesson Specialty Health, which supports The U.S. Oncology Network, a nationwide system of community-based oncology practices.


MetroMed

metromedkc.org [cached]

"The most likely thing is oncologists are going to start acting more like coaches of the team rather than the players and the quarterbacks," said health care lobbyist Matt Brow. "There will be a lot more nurse practitioners in the mix, a lot more physician assistants doing things, particularly around follow-up."

Brow works in Washington, D.C., as vice president of public policy for McKesson Specialty Health, which supports The U.S. Oncology Network, a nationwide system of community-based oncology practices.
His hour-long evening talk - which covered a range of topics that included the Medicare sustainable growth rate (SGR) and the potential impacts of this fall's elections - came before a mix of medical students, payors, physicians, and researchers.
Forecasts and Trends
On cancer, Brow said, increased demand for services could increase daily patient load at practices by as much as 75 percent. By the middle of the next decade, he said, the projected number of oncologists will be able to serve only about 90 percent of the expected demand for services.
Forecasts are for cancer diagnoses to grow at a much higher pace than the population as a whole, he said, and the gap will likely widen in the next 10 to 20 years.
The trends driving those figures are familiar to health care professionals across the board: an aging population and an increasing pool of insured patients.
Within the next decade, as Baby Boomers continue turning 65, Brow said the nation could experience a doubling of the Medicare population. "Imagine 80 million Medicare beneficiaries," he said. "That is a lot of people."
Meanwhile, he said, the Affordable Care Act should have a profound impact on the number of people without insurance. Projections, he said, estimate the nation will have roughly half the number of uninsured (about 31 million) than it would have had without the health reform law in the year 2024.
Shorter-term statistics also suggest that the ACA is helping to reduce the ranks of the uninsured, Brow said. Since the fourth quarter of 2013, Brow said survey results have found that the uninsured rate dropped from 18 percent to 15.6 percent.
On the topic of the health reform law, Brow also said that:
...
"The way to think about this is don't," Brow said.
...
But Congress has routinely passed "doc fix" legislation for the past decade to temporarily delay the cuts by adding each year's cost to an every-growing deficit, which Brow said now stands at about $350 billion.
Brow said there is little appetite in Congress to raid other parts of the budget to pay off that deficit - a move that would essentially pit doctors against other priorities, including spending allocated for military operations in Iraq and Afghanistan.
Meanwhile, he said, lawmakers have a built in incentive to maintain the status quo because it keeps the medical community beholden to Congress each and every year - creating a potential inducement for campaign support.
Politics and the Future
As for the elections this fall, Brow said conventional wisdom is that the Republicans will pick up the six seats needed to take control of the U.S. Senate while also retaining the majority in the House.
Brow said that Republican control of Congress during the waning days of the Democratic administration in the White House could result in a more flexible stance than President Obama has shown in the past.
A similar situation toward the end of the Clinton presidency, he said, resulted in compromise welfare reform legislation.
A wildcard in the equation, Brow said, is the Halbig case now pending before the U.S. Court of Appeals for the D.C. Circuit.
If the full court upholds the ruling of a three-judge panel, which said the government can only pay subsidies for health policies sold on state-based exchanges, Brow said Obama might be scrambling to save his signature domestic achievement.
"If the Halbig ruling comes out and knocks the wind out of the sale of Obamacare, and he has a year to see if he can fix it," Brow said, "on that day, all bets are off.


MetroMed

metromedkc.org [cached]

Metro Med is excited to host "How Policy Will Affect the Future of Cancer Care" with Matt Brow, VP of Public Policy for McKesson Specialty Health, this Tuesday, August 19th from 5:00 - 7:00 pm at the Metro Med offices on the Plaza.

Physician members, managed care professionals and business leaders are welcome to attend. Please RSVP to Stacy at sdemeyer@metromedkc.org.
The evening will include a presentation from Mr. Brow and discussion from participants. Metro Med will provide a light dinner and refreshments.
More about Matt Brow: Matt Brow is Vice President of Business Development & Public Policy for McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system to advance the science, technology and quality of care. McKesson Specialty Health (MSH) supports The US Oncology Network, one of the nation's largest networks of community-based oncologists. In this role, Matt develops and implements an overarching, strategic approach to growing the MSH provider business through partnership, merger and/or acquisition and serves as the lead point of coordination for large prospect physician practices and provider companies that may consider partnering with or being acquired by McKesson Specialty Health. Matt also directs the activities of McKesson Specialty Health's Government Relations & Public Policy staff, leads the division's Washington, DC office, federal and state legislative and regulatory initiatives, and oversees all related research and analysis projects, and public outreach and grassroots advocacy efforts in support of the division's federal and state public policy goals. He provides strategic direction for MSH as a member of the Leadership Team and the Cancer Operating Team and also serves as Executive Director of The US Oncology Network PAC.
Matt joined McKesson Specialty Health's predecessor company, US Oncology, in July 2004 and has been working in the legislative and political arena since 1996. Prior to joining the company, Matt worked closely with US Oncology and its affiliated practices in Virginia for over 4 years as Vice President of Kemper Consulting, one of Virginia's premier state government relations firms.
Matt received his BA in History and Political Science from the University of Richmond, Virginia and is a Fellow of the University of Virginia's Sorensen Institute of Political Leadership.


Financial Market | Albany News Now

www.albanynewsnow.com [cached]

Matt Brow, Vice President, Business Development and Public Policy, McKesson

...
Matthew Brow, Vice President for Business Development and Public Policy at McKesson, told Evidence-Based Oncology in the current issue that the Centers for Medicare and Medicaid Services (CMS) is reviewing a proposal from McKesson and NCCN to utilize their oncology clinical pathways. Brow told EBO, a news publication of The American Journal of Managed Care, that if the proposal is accepted, McKesson believes that CMS will roll it out as a pilot project in certain oncology practices and hospital settings sometime in 2014.
"We may be able to work on a framework in the first quarter, and start organizing the pilot perhaps six months later," Brow told EBO.

Similar Profiles

Other People with this Name

Other people with the name Brow

David Brow
Springfield Board of Realtors

Tristan Brow

Christian Brow
N3 LLC

Heidi Brow
San Luis Rey Watershed Council

Doug Brow
TRIOVEST

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory